Kala Pharmaceuticals(KALA) - 2022 Q3 - Quarterly Report

Table of Contents UNITED STATES (Exact name of registrant as specified in its charter) Delaware 27-0604595 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For ...